A Department of Veterans Affairs memo obtained by ProPublica erects new roadblocks to care for veterans with the rare but ...

The month of October is used to raise awareness for dozens of causes and illnesses each year. From breast cancer to domestic ...

Please provide your email address to receive an email when new articles are posted on . Patients with advanced muscle-invasive bladder cancer had lower risk for local recurrence with adjuvant ...

KNOXVILLE, Tenn., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the start of a preclinical study of its lead ...

Dr. Patrick J. Hensley shares the treatment landscape of non-muscle-invasive bladder, as well as how individual risk factors can alter treatment options. Non-muscle-invasive bladder cancer remains a ...

The world was shocked when NFL legend Deion Sanders revealed he’d overcome a private battle with cancer. And now that he’s back to feeling like his old self, Coach Prime is giving fans and supporters ...

The NFL Hall of Famer also discuss why he decided to share the news publicly. Deion Sanders is opening up about a fight that changed his life. The NFL Hall of Famer and Colorado Buffaloes head coach ...

Deion Sanders was diagnosed with an aggressive form of non-muscle invasive bladder cancer in April 2025. He opted for surgery to remove and reconstruct his bladder instead of undergoing 36 weeks of ...

Please provide your email address to receive an email when new articles are posted on . Most patients with non-muscle-invasive bladder cancer who received TAR-200 with gemcitabine achieved complete ...

Inlexzo is an intravesical gemcitabine releasing system that is inserted directly into the bladder through a urinary catheter. The Food and Drug Administration (FDA) has approved Inlexzo ™ ...

The FDA approved a gemcitabine intravesical system (Inlexzo) for adults with non-muscle-invasive bladder cancer (NMIBC), the agency announced on Tuesday. The indication for the chemotherapy-containing ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...